Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nexoptic Technology Corp V.NXO

Alternate Symbol(s):  NXOPF

NexOptic Technology Corp. is a Canada-based technology company. The Company is engaged in developing artificial intelligence (AI) and imaging products, which enhance how images are either captured, processed, experienced, transferred and/or stored. It is developing technologies relating to imagery and light concentration for lens and image capture systems. The Company's primary focus is its patented and patent pending AI for imaging called All Light Intelligent Imaging Solutions (Aliis). Aliis can reduce storage and streaming requirements needed for videos and images while also improving image quality in all types of environmental conditions. Aliis delivers by learning a camera profile and optimally enhancing, pixel by pixel, its quality and its resolution in a fraction of a second, using edge processing. Its NexCompress, a video compression enhancement solution, offers bandwidth and storage savings for video storage and streaming applications.


TSXV:NXO - Post by User

Comment by ScarletSpideron Oct 13, 2021 2:28am
216 Views
Post# 33999811

RE:RE:RE:RE:RE:RE:RE:Running 50% more than avg daily volume

RE:RE:RE:RE:RE:RE:RE:Running 50% more than avg daily volume
you are very welcome Topper. $5 would have come if this wasn't 4 to 5 years already in existence and those that traded really high especially with nothing was on spec and if they still have nothing it will implode as this. In some way the worst thing for stocks is constant revenue because it can be calculated and if the numbers don't justify pie in the sky prices they don't get there. $5 a share here means roughly at 150 million is 750 million. Realistically you would need strong revenue coupled with high gross profit margins which can lead to first EBITDA positive then to net profit overall..I talked about why I wasn't prepared to go less than 4 to 1 for nxo in exchange for mrs shares yet I traded what in the end was a 2 to 1 the other way and it was due to revenue. Despite mrs hitting 105 million in revenue for 2020 and so far 78 million for 2021 the share value is trading really low albeit in justly partly on perception of it being only a ppe based company the other part that after people hyped up ppe stocks and they went stupidly up when people came to know that companies may be losing or turn a modest profit margins the darlings became disaster. This is to the point I mentioned earlier. On ppe mrs has only a 5 to 12 percent profit margin which is peanuts you want 20 plus...the higher the better. The way I have seen is your gross divided by half at the very least will give you your net after all expenses are pulled out and if that is still higher than costs you have net profit for the quarter of not loss. EBITDA is the first measure of strength how healthy are companies with monies flow...Earnings Before Interest Taxes Depreciation and Amortization if you are EBITDA positive that is hard to achieve and so I have seen people use a 2 to 4 times multiplier on the amount obtained when dividing revenue from outstanding so if that number is 50 cents and you are EBITDA positive the stock theoretically should fall between $1.00 and a $2.00 if it is not then.50. Mrs made several EBITDA positive quarters. People are f'ing the shares badly there I took straight out dollar for dollar calculations meaning the total booked revenue to the full dilution 233 million booked ( 2017 to second quarter 2021 inclusive) to 200 million outstanding this is all booked again and that gives you $1.165 that is the bloody lowest it should trade but people are f'ing around and have it at about 46 million market cap or .23 actually less at today's close. Simply Wall Street has a qualified $3.74 and that is closer to where I put fair market value actually. They reassessed it before it was $5.79. People badly manipulated the stock it isn't even funny. This is why I did not go the other way easily despite again what I said. What if the equity went to .15 vs running because people manipulated as badly as they are at mrs even though I did say besides a real stinky .15 which was historic low for the year before how much worse could it really do? In any case, when nxo shows strong revenue and higher gross profit of 20 plus percent it should be able to burst so I am calculating on not only strong revenue but also higher profit margins. Stinky 7 or so percent gross profit margins ended in EBITDA positive quarters at mrs. Hype is one thing but in the end the numbers do catch up that is why if something with 0 revenue is above a buck especially multiple dollars take some monies out. Again I did qualify the past I wish I could show that. I said the stock due to potential is worth $2 under the Dugalas I further said depending on the contracts $2.50 or more. But after revenue wasn't coming I should have said less than $2.000 start think about selling...live and learn. Hence I find strategic positioning the best way with handling the crooked essence of the market regardless of whether it is competitors people loyal to stocks whatever. Because of the vast potential yes this remains a candidate for some crazy prices be it justified or not.
<< Previous
Bullboard Posts
Next >>